Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma

被引:14
作者
Huang, Xiaojun [1 ,2 ]
Qu, Ping [1 ,2 ]
Chen, Yibing [1 ,2 ]
Zhou, Xingchun [1 ,2 ]
Wu, Yousheng [1 ,2 ]
Liu, Fange [1 ,2 ]
Wang, Dandan [4 ]
Zhang, Jing [1 ,2 ]
An, Jiaze [3 ]
机构
[1] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Peoples R China
[3] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China
[4] Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Jinan 250062, Peoples R China
关键词
CD112; Hepatocellular carcinoma; Immunohistochemistry; Prognosis; Biomarker; NATURAL-KILLER-CELLS; POLIOVIRUS RECEPTOR; CANCER-PATIENTS; LIGANDS; INVOLVEMENT; PROGNOSIS; CD155; LIVER; NK;
D O I
10.1016/j.humpath.2014.06.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD112 as an important ligand of CD226 can stimulate the natural killer (NK) cell mediated target cell lysis. Previous studies have reported that CD112 is involved in cancer initiation and progression. However, its expression and clinical significance in hepatocellular carcinoma (HCC) have never been investigated. In this study, we used immunohistochemistry to examine CD112 expression in cancer and pericancer tissues from 159 HCC cases. Western blot and immunofluorescence were used to detect CD112 expression in HCC cell lines. chi(2) Test was used to assess the association of CD112 expression with clinicopathological characteristics, whereas Kaplan-Meier survival function and Cox proportional hazards regression model were used to explore the association between CD112 expression and clinical outcome of patients with HCC. Overall, CD112 expression was significantly reduced in HCC tissues when compared with adjacent pericanber liver tissues (P < .001). Western blot and immunofluorescence analyses showed. that most HCC cell lines had low CD112 expression level. Furthermore, low CD112 expression was significantly associated with high serum alpha-fetoprotein level (P = .004) in patients with HCC. Kaplan-Meier analysis showed that patients with low CD112 expression had poorer postsurgery overall survival than those with high CD112 expression (log-rank P = .045). In conclusion, our findings demonstrate that the down-regulation of CD112 may be an important mechanism through which HCC cells evade the natural killer cell mediated immunosurveillance, and thus, CD112 may be a useful biomarker to assess the immunologic niche of HCC. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:1944 / 1950
页数:7
相关论文
共 50 条
[41]   High expression of Rap2A is associated with poor prognosis of patients with hepatocellular carcinoma [J].
Zheng, Xuqing ;
Zhao, Wenxiu ;
Ji, Piyou ;
Zhang, Kang ;
Jin, Jianbin ;
Feng, Min ;
Wang, Fei ;
Zheng, Sen ;
Wang, Xiaomin .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (09) :9607-+
[42]   The Expression of CD146 Predicts a Poor Overall Survival in Patients with Adenocarcinoma of the Lung [J].
Oka, Soichi ;
Uramoto, Hidetaka ;
Chikaishi, Yasuhiro ;
Tanaka, Fumihiro .
ANTICANCER RESEARCH, 2012, 32 (03) :861-864
[43]   Increased adiponectin associated with poor survival in hepatocellular carcinoma [J].
Shen-Nien Wang ;
Sheau-Fang Yang ;
Hsin-Hui Tsai ;
King-Teh Lee ;
Yao-Tsung Yeh .
Journal of Gastroenterology, 2014, 49 :1342-1351
[44]   Low expression of B-cell-associated protein 31 in human primary hepatocellular carcinoma correlates with poor prognosis [J].
Tan, Ning ;
Liu, Qinyi ;
Liu, Xiaojia ;
Gong, Zhiwei ;
Zeng, Yonglian ;
Pan, Guangdong ;
Xu, Qing ;
He, Songqing .
HISTOPATHOLOGY, 2016, 68 (02) :221-229
[45]   A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients [J].
Song, Byeong Geun ;
Kim, Min Ji ;
Sinn, Dong Hyun ;
Kang, Wonseok ;
Gwak, Geum-Youn ;
Paik, Yong-Han ;
Choi, Moon Seok ;
Lee, Joon Hyeok ;
Koh, Kwang Cheol ;
Paik, Seung Woon .
DIGESTIVE AND LIVER DISEASE, 2021, 53 (02) :210-215
[46]   Survivin expression in hepatocellular carcinoma. Correlation with clinicopathological characteristics and overall survival [J].
Kapiris, Ioannis ;
Nastos, Konstantinos ;
Karakatsanis, Anestis ;
Theodosopoulos, Theodosios ;
Karandrea, Despoina ;
Kondi-Pafiti, Agatha ;
Contis, John .
JOURNAL OF BUON, 2019, 24 (05) :1934-1942
[47]   High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma [J].
Wu, Yi-Ru ;
Lee, Yi-Chen ;
Li, Wei-Ming ;
Hsu, Wei-Chi ;
Lin, Hui-Hui ;
Chang, Lin-Li ;
Huang, A-Mei ;
Jhan, Jhen-Hao ;
Wu, Wen-Jeng ;
Li, Ching-Chia ;
Lee, Hsiang-Ying ;
Yeh, Hsin-Chih ;
Ke, Hung-Lung .
PATHOLOGY INTERNATIONAL, 2021, 71 (07) :463-470
[48]   Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma [J].
Lu, Jeng-Wei ;
Chang, Jan-Gowth ;
Yeh, Kun-Tu ;
Chen, Rong-Ming ;
Tsai, Jeffrey J. P. ;
Hu, Rouh-Mei .
MEDICAL ONCOLOGY, 2011, 28 :S239-S245
[49]   High GOLPH3 expression is associated with poor prognosis and invasion of hepatocellular carcinoma [J].
Li, Qian ;
Ma, Yuwen ;
Xu, Wanpeng .
MOLECULAR MEDICINE REPORTS, 2015, 11 (06) :4315-4320
[50]   Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients [J].
Bignotti, Eliana ;
Todeschini, Paola ;
Calza, Stefano ;
Falchetti, Marcella ;
Ravanini, Maria ;
Tassi, Renata A. ;
Ravaggi, Antonella ;
Bandiera, Elisabetta ;
Romani, Chiara ;
Zanotti, Laura ;
Tognon, Germana ;
Odicino, Franco E. ;
Facchetti, Fabio ;
Pecorelli, Sergio ;
Santin, Alessandro D. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (05) :944-953